首页|三七通舒胶囊联合奥拉西坦治疗脑梗死后血管性痴呆的临床效果及对血液流变学指标的影响

三七通舒胶囊联合奥拉西坦治疗脑梗死后血管性痴呆的临床效果及对血液流变学指标的影响

扫码查看
目的:探讨脑梗死(CI)后血管性痴呆(VD)采用三七通舒胶囊联合奥拉西坦治疗的临床效果及对血液流变学指标的影响.方法:选取2021年1月—2023年1月辽宁省金秋医院收治的共计102例CI后VD患者,以随机数字表法分成研究组(n=51)与对照组(n=51),对照组给予奥拉西坦治疗,研究组给予三七通舒胶囊联合奥拉西坦治疗,均治疗 2 个月.比较两组临床疗效、痴呆程度、血液流变学、认知功能及日常生活能力.结果:研究组治疗总有效率(92.16%)较对照组(76.47%)高,差异有统计学意义(P<0.05);治疗后两组临床痴呆评定量表(CDR)评分均降低(P<0.05),研究组较对照组低,差异有统计学意义(P<0.05);治疗后两组全血低切黏度、全血高切黏度、血浆黏度均降低(P<0.05),研究组均较对照组低,差异均有统计学意义(P<0.05);治疗后两组简易智能精神状态量表(MMSE)、蒙特利尔认知评估量表(MoCA)、Barthel指数评分均升高(P<0.05),研究组均较对照组高,差异均有统计学意义(P<0.05).结论:三七通舒胶囊联合奥拉西坦用于治疗CI后VD,能够提高临床效果,减轻痴呆程度,改善血液流变学,促进认知功能、日常生活能力提高.
Clinical Effect of Sanqi Tongshu Capsules Combined with Oxiracetam in the Treatment of Vascular Dementia after Cerebral Infarction and Its Influence on Hemorheology Indexes
Objective:To explore the clinical effect of Sanqi Tongshu Capsules combined with Oxiracetam in the treatment of vascular dementia(VD)after cerebral infarction(CI)and its influence on hemorheology indexes.Method:A total of 102 patients with VD after CI who were admitted in Liaoning Jinqiu Hospital from January 2021 to January 2023 were selected and divided into the study group(n=51)and the control group(n=51)by random number table method.The control group was treated with Oxiracetam,and the study group was treated with Sanqi Tongshu Capsules combined with Oxiracetam.All patients were treated for 2 months.The clinical efficacy,dementia degree,hemorheology,cognitive function and ability of daily living of the two groups were compared.Result:The total effective rate of the study group(92.16%)was higher than that(76.47%)of the control group,the difference was statistically significant(P<0.05).After treatment,the clinical dementia rating scale(CDR)scores in both groups were decreased(P<0.05),and the CDR score in the study group was lower than that in the control group,the difference was statistically significant(P<0.05).After treatment,the whole blood low shear viscosity,whole blood high shear viscosity and plasma viscosity in both groups were decreased(P<0.05),and those in the study group were lower than those in the control group,the differences were statistically significant(P<0.05).After treatment,the mini-mental state examination(MMSE),Montreal cognitive assessment(MoCA)and Barthel index scores in both groups were increased(P<0.05),and those in the study group were higher than those in the control group,the differences were statistically significant(P<0.05).Conclusion:Sanqi Tongshu Capsules combined with Oxiracetam in the treatment of VD after CI can improve the clinical efficacy,reduce the degree of dementia,improve hemorheology,and promote cognitive function and daily living ability.

Cerebral infarctionVascular dementiaSanqi Tongshu CapsulesOxiracetamHemorheology

佟玲

展开 >

辽宁省金秋医院神经内二科 辽宁 沈阳 110000

脑梗死 血管性痴呆 三七通舒胶囊 奥拉西坦 血液流变学

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(6)
  • 20